Susvimo (ranibizumab, implante oftálmico)

Susvimo is approved for the treatment of:

This condition leads to rapid and severe vision loss due to abnormal blood vessel growth beneath the retina.

Susvimo is sometimes studied for off-label use in:

However, its port delivery system is only FDA-approved for use in nAMD at this time.

Susvimo is a refillable port delivery system that delivers ranibizumab continuously into the eye over several months. It is a sustained-release, anti-VEGF therapy, offering a long-term alternative to monthly intravitreal injections. Ranibizumab works by inhibiting vascular endothelial growth factor A (VEGF-A), which contributes to abnormal blood vessel growth and leakage in retinal diseases.

USA: Genentech (Roche Group)

Mexico: Roche México, S.A. de C.V.

Canada: Hoffmann-La Roche Limited (Roche Canada)

Susvimo is approved in the U.S. and Canada, with availability through specialized distribution networks. Its distribution in Mexico is emerging and may be limited to hospital or specialty access settings. Canada and Mexico may offer significant savings, particularly for uninsured or underinsured U.S. patients.

Canada: ~30–40% savings vs. U.S. retail pricing
Mexico: ~25–35% savings vs. U.S. retail pricing
(Savings may vary based on refill availability, controlled status, specialty handling, and limited inventory.)

Susvimo is available through retina specialists and surgical ophthalmology centers with access to:

Availability may vary depending on practice certification for Susvimo implantation.

This medication is accessed through fully licensed Canadian pharmacies regulated by Health Canada. All pharmacies included in the MedicalMex network undergo a rigorous review and verification process to ensure compliance with national standards, patient safety, and medication authenticity.

You are working directly with MedicalMex Inc., a U.S.-based company that helps eligible patients safely access affordable medications from Canada — with compliance and full-service concierge support at every step.

This medication is also available through certified pharmacies in Mexico regulated by COFEPRIS (Mexico’s national health authority). All partners in the MedicalMex network must pass a rigorous review and certification process before being approved for patient access.

You are working directly with MedicalMex Inc., a U.S.-based company that manages every detail — from medical and travel logistics to prescription compliance — providing secure, affordable access to life-saving medications from Mexico.

Common side effects:

Serious risks include:

These events are typically managed by trained ophthalmic specialists, and patients must follow up regularly.

Intravitreal Injection Alternatives for nAMD:
Eylea (aflibercept)
Lucentis (ranibizumab, monthly injections)
Vabysmo (faricimab)
Avastin (off-label)

Susvimo offers an alternative to monthly injections by maintaining drug levels via a long-acting implant. Suitability should be discussed with a retina specialist.